Literature DB >> 26228771

Suppression of the reticuloendothelial system using λ-carrageenan to prolong the circulation of gold nanoparticles.

Isidro B Magaña1, Raghuvara B Yendluri2, Pratik Adhikari1, Glenn P Goodrich3, Jon A Schwartz3, Eric A Sherer4, Dennis Patrick O'Neal1.   

Abstract

AIM: Gold nanoparticles are employed for imaging and treatment of surgically inaccessible tumors owing to their inherent optical absorption and ability to extravasate through intravenous distribution. These nanoparticles are cleared from the blood by the reticuloendothelial system (RES) as expected given their size. MATERIALS &
METHODS: This study demonstrates the effects of RES blockade through the intravenous administration of λ-carrageenan, resulting in a decrease in the median clearance rate from 18.9 (95% CrI: 15.9-22.6) to 11.2 (95% CrI: 8.8-13.9) μl/min and an increase in nanoparticle circulation half-life t(½)( = 264 ± 73 vs 160 ± 22 min; p < 0.01).
RESULTS: This 59.3% decrease in clearance is greater than the 15% previously reported for liposomes [ 1 ].
CONCLUSION: The primary benefit of nontoxic RES blockade is to increase the circulation time, where traditional particle modification is ineffective or impractical.

Entities:  

Keywords:  RES clearance; accelerated blood clearance; gold nanoparticles; gold nanorods; gold nanoshells; pharmacokinetics; reticuloendothelial system blockade; λ-carrageenan

Mesh:

Substances:

Year:  2015        PMID: 26228771     DOI: 10.4155/tde.15.33

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  4 in total

1.  Effect of removing Kupffer cells on nanoparticle tumor delivery.

Authors:  Anthony J Tavares; Wilson Poon; Yi-Nan Zhang; Qin Dai; Rickvinder Besla; Ding Ding; Ben Ouyang; Angela Li; Juan Chen; Gang Zheng; Clinton Robbins; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

Review 2.  Mechanisms of immune response to inorganic nanoparticles and their degradation products.

Authors:  Raziye Mohammapdour; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2021-11-02       Impact factor: 15.470

Review 3.  A Nanoparticle's Journey to the Tumor: Strategies to Overcome First-Pass Metabolism and Their Limitations.

Authors:  Joshua J Milligan; Soumen Saha
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

Review 4.  A Metal-Containing NP Approach to Treat Methicillin-Resistant Staphylococcus aureus (MRSA): Prospects and Challenges.

Authors:  Wendy Wai Yeng Yeo; Sathiya Maran; Amanda Shen-Yee Kong; Wan-Hee Cheng; Swee-Hua Erin Lim; Jiun-Yan Loh; Kok-Song Lai
Journal:  Materials (Basel)       Date:  2022-08-23       Impact factor: 3.748

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.